|
|
|
|
| LEADER |
04982nmm a2200409 u 4500 |
| 001 |
EB000357022 |
| 003 |
EBX01000000000000000210074 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
130626 ||| eng |
| 020 |
|
|
|a 9780387893709
|
| 100 |
1 |
|
|a Sosa, Aníbal de J.
|e [editor]
|
| 245 |
0 |
0 |
|a Antimicrobial Resistance in Developing Countries
|h Elektronische Ressource
|c edited by Aníbal de J. Sosa, Denis K. Byarugaba, Carlos F. Amábile-Cuevas, Po-Ren Hsueh, Samuel Kariuki, Iruka N. Okeke
|
| 250 |
|
|
|a 1st ed. 2010
|
| 260 |
|
|
|a New York, NY
|b Springer New York
|c 2010, 2010
|
| 300 |
|
|
|a XXIII, 554 p
|b online resource
|
| 505 |
0 |
|
|a Resistance in Reservoirs and Human Commensals -- Antimicrobial Use and Misuse -- Determinants of Antimicrobial Use: Poorly Understood–Poorly Researched -- Antimicrobial Use and Resistance in Africa -- Antimicrobial Drug Resistance in Asia -- Antimicrobial Drug Resistance in Latin America and the Caribbean -- Hospital Infections by Antimicrobial-Resistant Organisms in Developing Countries -- Cost, Policy and Regulation of Antimicrobials -- The Economic Burden of Antimicrobial Resistance in the Developing World -- Strengthening Health Systems to Improve Access to Antimicrobials and the Containment of Resistance -- The Role of Unregulated Sale and Dispensing of Antimicrobial Agents on the Development of Antimicrobial Resistance in Developing Countries -- Counterfeit and Substandard Anti-infectives in Developing Countries -- Strategies to contain AMR -- Containment of Antimicrobial Resistance in Developing Countries and Lessons Learned --
|
| 505 |
0 |
|
|a General Issues in Antimicrobial Resistance -- Global Perspectives of Antibiotic Resistance -- Mechanisms of Antimicrobial Resistance -- Poverty and Root Causes of Resistance in Developing Countries -- What the Future Holds for Resistance in Developing Countries -- The Introduction of Antimicrobial Agents in Resource-Constrained Countries: Impact on the Emergence of Resistance -- The Human Impact of Resistance -- Human Immunodeficiency Virus: Resistance to Antiretroviral Drugs in Developing Countries -- Drug Resistance in Malaria in Developing Countries -- Drug Resistance in Mycobacterium tuberculosis -- Antifungal Drug Resistance in Developing Countries -- Drug Resistance in African Trypanosomiasis -- Antimicrobial Resistance in Enteric Pathogens in Developing Countries -- Bacterial-Resistant Infections in Resource-Limited Countries -- Prevalence of Resistant Enterococci in Developing Countries -- Antimicrobial Resistance in Gram-Negative Bacteria from Developing Countries --
|
| 505 |
0 |
|
|a Surveillance of Antibiotic Resistance in Developing Countries: Needs, Constraints and Realities -- Vaccines: A Cost-Effective Strategy to Contain Antimicrobial Resistance -- Teaching Appropriate Antibiotic Use in Developing Countries -- Containing Global Antibiotic Resistance: Ethical Drug Promotion in the Developing World -- News Media Reporting of Antimicrobial Resistance in Latin America and India
|
| 653 |
|
|
|a Public health
|
| 653 |
|
|
|a Microbiology
|
| 653 |
|
|
|a Microbiology
|
| 653 |
|
|
|a Immunology
|
| 653 |
|
|
|a Immunology
|
| 653 |
|
|
|a Infectious diseases
|
| 653 |
|
|
|a Pharmacology
|
| 653 |
|
|
|a Infectious Diseases
|
| 653 |
|
|
|a Public Health
|
| 653 |
|
|
|a Pharmacology/Toxicology
|
| 700 |
1 |
|
|a Byarugaba, Denis K.
|e [editor]
|
| 700 |
1 |
|
|a Amábile-Cuevas, Carlos F.
|e [editor]
|
| 700 |
1 |
|
|a Hsueh, Po-Ren
|e [editor]
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b Springer
|a Springer eBooks 2005-
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/978-0-387-89370-9?nosfx=y
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 579
|
| 520 |
|
|
|a "Antimicrobial Resistance in Developing Countries, edited by Drs. Anibal Sosa and Denis Byarugaba, and their associate editors is unique in focusing on antimicrobial resistance as it relates to, and threatens developing countries. It is curious that it has taken this long to produce a book dedicated to antibiotic resistance in this part of the world. One can ask "why?", since resistance is and has been so common there. In fact, whereas resistance has been addressed for the past four decades by experts in the industrialized world, studies describing the problem and the public health situation in the developing world have lagged behind. Although we have learned much from studies of the genetics and molecular biology of the problem from investigations in industrialized countries, it is in developing countries where more studies and efforts are needed. With travel encouraging the transport of microbes, the information in this book will have wide sweeping benefit, not only for developing countries, but also for the world at large. Surveillance of resistance and the prevention of resistance need attention on a worldwide basis. Improving antibiotic use requires a global effort". Prof. Stuart B. Levy Tufts University School of Medicine The Alliance for Prudent Use of Antibiotics Boston, MA.
|